Melissa Starovasnik
Director/Board Member chez TWIST BIOSCIENCE CORPORATION
Fortune : 588 588 $ au 31/03/2024
Profil
Melissa A.
Starovasnik is an Independent Director at Twist Bioscience Corp.
She previously worked as Vice President-Protein Sciences at Genentech, Inc. from 2011 to 2017.
She received her undergraduate degree in 1987 and her doctorate in 1992 from the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TWIST BIOSCIENCE CORP.
0,03% | 06/02/2024 | 17 155 ( 0,03% ) | 588 588 $ | 31/03/2024 |
Postes actifs de Melissa Starovasnik
| Sociétés | Poste | Début |
|---|---|---|
| TWIST BIOSCIENCE CORPORATION | Director/Board Member | 06/08/2021 |
Anciens postes connus de Melissa Starovasnik
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 |
Formation de Melissa Starovasnik
| University of Washington | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TWIST BIOSCIENCE CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
